Fichas

BCG treatment in high-risk non-muscle invasive bladder tumours: possible situations after its use By Jorge Huguet

BCG is an effective treatment for high-risk non-muscle invasive bladder tumors, with response rates of around 70%. However, progression during BCG treatment can occur in 9.5%-21% of cases, resulting in a worse patient prognosis. If there is no response to BCG or BCG failure occurs, the European Association of Urology (EAU) guidelines have defined different

BCG treatment in high-risk non-muscle invasive bladder tumours: possible situations after its use By Jorge Huguet Read More »

Vacuum Devices

Penile vacuum devices are considered safe and effective non-invasive treatments commonly used in urology for treating erectile dysfunction, Peyronie’s disease, and for penile rehabilitation following radical prostatectomy, urethroplasty surgeries, or penile prosthesis implantation. The device consists of a cylinder that is placed over the penis, creating a vacuum that draws blood into the penis, resulting

Vacuum Devices Read More »

Peyronie’s disease

Peyronie’s disease is a condition that affects the penis, causing the development of a fibrous plaque that can result in curvature, pain, and other sexual dysfunction. The disease is named after Francois Gigot de la Peyronie, a French surgeon who first described the condition in 1743. The exact cause of Peyronie’s disease is not fully

Peyronie’s disease Read More »

Imaging in prostate cancer

In the evaluation of patients with prostate cancer, an adequate initial assessment and tumour extension is crucial for an adequate management of the disease. Knowing the available imaging tests and their indication is necessary for a correct evaluation and treatment approach. If you want to know more about the imaging tests available for prostate cancer

Imaging in prostate cancer Read More »

Combined hormone and radiotherapy treatment in local treatment and biochemical recurrence of prostate cancer

Radiotherapy (RT) is an alternative treatment for localized prostate cancer (PC) with the same cure rates as radical prostatectomy (RP). Radiation dose is directly related to disease control; however, toxicity is a limitation. Androgen deprivation therapy (ADT) has a cytotoxic effect on tumor cells, which associated with RT has a synergistic effect, increasing sensitivity to

Combined hormone and radiotherapy treatment in local treatment and biochemical recurrence of prostate cancer Read More »

Subscribe to our newsletter